盘龙药业 - Financials

盘龙药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	974.0M	981.0M	974.0M	887.0M	670.0M	611.0M	489.0M	377.0M	305.0M	256.0M	246.0M	227.0M
Revenue Growth %	-0.7%	0.7%	9.8%	32.4%	9.7%	24.9%	29.7%	23.6%	19.1%	4.1%	8.4%	--
Total Revenue	974.0M	981.0M	974.0M	887.0M	670.0M	611.0M	489.0M	377.0M	305.0M	256.0M	246.0M	227.0M
Cost Of Revenue	382.0M	413.0M	408.0M	370.0M	253.0M	186.0M	141.0M	116.0M	113.0M	90.5M	72.3M	69.9M
+Gross Profit	592.0M	568.0M	566.0M	517.0M	417.0M	425.0M	348.0M	261.0M	192.0M	165.5M	173.7M	157.1M
Gross Margin %	60.8%	57.9%	58.1%	58.3%	62.2%	69.6%	71.2%	69.2%	63.0%	64.7%	70.6%	69.2%
Total Operating Cost	846.0M	852.0M	854.0M	777.0M	584.0M	535.0M	434.0M	328.0M	261.0M	208.0M	202.0M	192.0M
Selling Expenses	367.0M	361.0M	363.0M	333.0M	263.0M	281.0M	238.0M	170.0M	120.0M	93.0M	103.0M	97.1M
Admin Expenses	69.8M	57.7M	53.4M	52.9M	42.8M	41.8M	38.9M	29.5M	23.5M	20.5M	19.4M	21.6M
Rd Expenses	37.5M	20.3M	18.2M	14.0M	13.0M	13.1M	8.3M	7.2M	--	--	--	--
Finance Expenses	-23.3M	-15.8M	-3.1M	-8.1M	304,600	-446,200	-2.1M	-1.0M	357,700	857,100	2.6M	1.2M
+Operating Income	138.0M	135.0M	123.0M	113.0M	95.0M	86.4M	66.2M	50.1M	44.4M	48.3M	43.4M	34.3M
Operating Margin %	14.2%	13.8%	12.6%	12.7%	14.2%	14.1%	13.5%	13.3%	14.6%	18.9%	17.7%	15.1%
Non Operating Income	193,500	441,500	456,200	690,900	2.3M	1.1M	9.8M	379,600	2.4M	1.3M	2.1M	3.7M
Non Operating Expenses	1.6M	6.1M	4.3M	4.2M	2.8M	3.9M	658,300	483,300	579,000	32,100	28,400	1.0M
Investment Income	630,900	-1.6M	-112,600	--	5.6M	8.8M	9.2M	--	--	--	--	--
Fair Value Change Income	--	--	--	--	--	213,900	--	--	--	--	--	--
Asset Disposal Income	-14,100	168,200	--	--	145,500	194,300	148,600	289,100	147,500	--	--	--
Asset Impairment Loss	225,000	992,200	241,200	90,200	2.8M	1.6M	2.0M	938,200	185,300	30,400	1.4M	-159,100
Other Income	10.1M	7.2M	3.0M	2.3M	2.8M	1.2M	1.2M	1.3M	--	--	--	--
Income Before Tax	137.0M	129.0M	119.0M	109.0M	94.5M	83.6M	75.3M	50.0M	46.2M	49.5M	45.5M	37.0M
Income Tax	17.0M	17.7M	16.0M	14.5M	13.4M	11.8M	10.6M	6.3M	6.6M	6.8M	6.6M	5.1M
+Net Income	120.0M	112.0M	103.0M	94.6M	81.1M	71.8M	64.7M	43.7M	39.6M	42.7M	38.9M	31.9M
Net Margin %	12.3%	11.4%	10.6%	10.7%	12.1%	11.7%	13.2%	11.6%	13.0%	16.7%	15.8%	14.0%
Net Income Attributable	120.0M	110.0M	101.0M	93.2M	79.1M	71.8M	64.7M	43.7M	39.5M	42.6M	40.1M	32.9M
Minority Interest	-346,900	1.1M	2.0M	1.4M	2.0M	--	--	--	52,600	58,900	-1.2M	-1.0M
Eps Basic	1.15	1.15	1.18	1.09	0.92	0.83	0.75	0.65	0.61	0.66	0.62	0.51
Eps Diluted	1.15	1.13	1.17	1.09	0.92	0.83	0.75	0.65	0.61	0.66	0.62	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	1.2B	1.1B	823.0M	419.0M	382.0M	118.0M	85.1M	301.0M	126.0M	80.5M	105.0M	67.8M
Trading Financial Assets	--	--	--	--	--	50.2M	--	--	--	--	--	--
Accounts Receivable	368.0M	384.0M	444.0M	361.0M	321.0M	203.0M	166.0M	147.0M	111.0M	95.7M	83.6M	77.3M
Notes Receivable	127.0M	92.4M	94.9M	85.0M	82.2M	67.5M	63.8M	50.9M	35.1M	38.7M	31.5M	30.5M
Notes And Accounts Receivable	495.0M	476.0M	538.0M	446.0M	403.0M	270.0M	229.0M	198.0M	147.0M	134.0M	115.0M	108.0M
Prepayments	5.8M	17.2M	16.7M	19.6M	7.3M	3.6M	4.0M	6.9M	4.8M	1.9M	1.2M	1.1M
Inventory	95.6M	77.6M	94.6M	66.8M	66.4M	57.9M	39.9M	32.0M	28.7M	29.9M	29.9M	31.8M
Total Current Assets	1.8B	1.7B	1.5B	956.0M	863.0M	691.0M	598.0M	541.0M	308.0M	248.0M	253.0M	221.0M
Long Term Equity Investment	10.2M	9.7M	9.9M	--	--	--	--	--	--	--	--	--
Fixed Assets	--	340.0M	349.0M	120.0M	113.0M	122.0M	142.0M	136.0M	127.0M	54.8M	55.4M	42.1M
Fixed Assets Total	380.0M	340.0M	349.0M	120.0M	113.0M	122.0M	142.0M	136.0M	127.0M	54.8M	55.4M	42.1M
Construction In Progress	--	29.3M	3.8M	152.0M	84.2M	22.0M	--	4.6M	360,400	62.0M	38.3M	4.1M
Construction In Progress Total	56.0M	29.3M	3.8M	152.0M	84.2M	22.0M	--	4.6M	360,400	62.0M	38.3M	4.1M
Intangible Assets	51.4M	52.8M	54.9M	56.3M	57.8M	59.4M	61.0M	62.6M	64.0M	64.2M	33.4M	12.2M
Long Term Deferred Expenses	3.1M	2.9M	1.3M	24,700	88,700	110,600	--	--	--	--	--	--
Total Non Current Assets	508.0M	447.0M	449.0M	374.0M	299.0M	238.0M	219.0M	212.0M	197.0M	185.0M	148.0M	121.0M
Total Assets	2.3B	2.1B	1.9B	1.3B	1.2B	929.0M	818.0M	753.0M	504.0M	433.0M	401.0M	342.0M
Short Term Borrowings	50.0M	100.0M	117.0M	50.0M	10.0M	--	--	--	20.0M	20.0M	40.0M	20.0M
Accounts Payable	108.0M	91.4M	122.0M	66.0M	58.8M	36.6M	41.0M	50.9M	49.9M	47.5M	35.5M	34.4M
Advance Receipts	218,000	355,600	555,200	190,100	389,700	2.5M	4.5M	3.4M	3.1M	2.8M	2.0M	2.1M
Contract Liabilities	3.7M	5.5M	13.3M	4.7M	2.0M	--	--	--	--	--	--	--
Total Current Liabilities	446.0M	480.0M	903.0M	438.0M	344.0M	235.0M	187.0M	179.0M	157.0M	132.0M	143.0M	123.0M
Long Term Borrowings	98.5M	--	27.4M	40.4M	53.4M	--	--	--	--	--	--	--
Total Non Current Liabilities	197.0M	93.4M	80.5M	85.4M	82.7M	19.5M	19.2M	18.6M	19.4M	12.8M	11.9M	8.2M
Total Liabilities	643.0M	574.0M	983.0M	523.0M	427.0M	254.0M	206.0M	197.0M	177.0M	144.0M	155.0M	132.0M
Paid In Capital	106.0M	106.0M	86.7M	86.7M	86.7M	86.7M	86.7M	86.7M	65.0M	65.0M	65.0M	65.0M
Capital Reserve	817.0M	818.0M	259.0M	272.0M	271.0M	271.0M	271.0M	271.0M	109.0M	109.0M	109.0M	114.0M
Surplus Reserve	77.5M	65.7M	56.1M	47.4M	39.9M	32.4M	25.7M	19.3M	14.9M	11.4M	7.3M	3.3M
Retained Earnings	660.0M	574.0M	493.0M	416.0M	343.0M	284.0M	228.0M	178.0M	139.0M	103.0M	64.4M	29.0M
Minority Equity	2.0M	2.2M	18.0M	15.8M	14.9M	--	--	--	--	636,000	577,100	-692,000
Equity Attributable	1.6B	1.5B	930.0M	791.0M	721.0M	675.0M	612.0M	556.0M	328.0M	288.0M	246.0M	212.0M
Total Equity	1.6B	1.6B	948.0M	807.0M	736.0M	675.0M	612.0M	556.0M	328.0M	289.0M	246.0M	211.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	1.0B	1.0B	976.0M	922.0M	677.0M	614.0M	500.0M	358.0M	318.0M	246.0M	249.0M	205.0M
Total Operating Cash Inflow	1.1B	1.1B	1.0B	968.0M	740.0M	660.0M	537.0M	388.0M	335.0M	262.0M	263.0M	212.0M
Cash Paid For Goods	362.0M	406.0M	420.0M	383.0M	242.0M	195.0M	138.0M	105.0M	95.7M	61.2M	57.3M	33.1M
Cash Paid To Employees	80.0M	79.3M	76.2M	66.6M	52.2M	46.6M	36.4M	29.8M	26.3M	22.7M	23.0M	20.4M
Taxes Paid	98.8M	95.7M	93.2M	84.7M	71.3M	75.8M	69.7M	61.3M	43.4M	39.0M	38.8M	33.8M
Total Operating Cash Outflow	934.0M	976.0M	923.0M	852.0M	648.0M	592.0M	490.0M	359.0M	273.0M	222.0M	215.0M	187.0M
Operating Cash Flow	157.0M	104.0M	125.0M	116.0M	92.2M	67.9M	46.8M	28.4M	62.0M	40.6M	48.6M	25.4M
Total Investing Cash Inflow	2.0M	12.4M	28.3M	28,600	663.0M	588.0M	329.0M	3.0M	17.2M	1.2M	13.8M	1.2M
Total Investing Cash Outflow	106.0M	74.8M	65.8M	85.8M	493.0M	615.0M	576.0M	23.4M	27.7M	45.1M	43.4M	35.0M
Investing Cash Flow	-104.0M	-62.4M	-37.6M	-85.7M	170.0M	-26.7M	-247.0M	-20.5M	-10.5M	-43.9M	-29.6M	-33.8M
Cash From Borrowings	150.0M	134.0M	157.0M	50.0M	107.0M	--	--	--	20.0M	20.0M	40.0M	20.0M
Dividends And Interest Paid	24.5M	24.3M	21.1M	17.9M	16.5M	8.7M	8.7M	358,900	1.3M	1.4M	1.6M	1.8M
Debt Repayments	100.0M	167.0M	103.0M	10.0M	57.7M	--	--	20.0M	20.0M	40.0M	20.0M	19.0M
Total Financing Cash Inflow	150.0M	433.0M	447.0M	51.7M	109.0M	--	--	188.0M	20.0M	20.0M	49.9M	20.5M
Total Financing Cash Outflow	136.0M	196.0M	131.0M	44.7M	107.0M	8.7M	16.5M	20.4M	26.3M	41.4M	31.5M	21.2M
Financing Cash Flow	14.3M	237.0M	316.0M	7.0M	2.2M	-8.7M	-16.5M	168.0M	-6.3M	-21.4M	18.4M	-742,800
Net Change In Cash	67.4M	279.0M	404.0M	37.3M	264.0M	32.6M	-216.0M	176.0M	45.2M	-24.6M	37.3M	-9.1M
Ending Cash Balance	1.2B	1.1B	823.0M	419.0M	382.0M	118.0M	85.1M	301.0M	126.0M	80.5M	105.0M	67.8M
Capex	82.1M	62.5M	55.8M	80.7M	71.2M	33.6M	20.1M	23.4M	17.1M	45.1M	32.4M	30.6M